Medica Catalogue

Israel Medical Innovation
2011
www.israelmedicalinnovation.com
Come meet us at hall 16: G40 in
2011
Page
Contents
3 7 14 60
Table of Contents (By Category) Table of Contents (By Alphabetical Order) Company Profiles Schedule a Meeting
2011
Table of Contents (by category)

Category
Click on Companys name for more details
Company
Aesthetics and Dermatology
Cnoga Coolsense Erika Carmel Gilco Pharm Tav Tech Ltd
Cardiovascular and Peripheral Vascular
BSP Biological Signal Processing Cnoga Elitar Medical HypnoCore Itamar Medical Shina Systems Sion Biotext Medical
Diagnostics
3QBD BSP Biological Signal Processing DYN Diagnostics Elitar Medical Itamar Medical Medoc HypnoCore Itamar Medical Vasa Applied Technologies Sialo Technology
Disposables and Implantable
Albaad Beth-El Industreis Biovo Technologies ETView FirstCare Intromedix Mizra Medical Nava Group Noam Urim Enterprises OHK Medical Devices Sion Biotext Medical Toefix Sialo Technology Vasa Applied Technologies Xenolith Medical
Schedule a Meeting at
Return to Table of Content
2011

Category
Company
E.M.S
ETView FirstCare Flight Medical Gilco Pharm
General Health
Aerotel Albaad Beth-El Industreis Cnoga Coolsense EarlySense Elitar Medical Itamar Medical Mizra Medical Motorica Nava Group
General Surgery
ETView FlowSense Intromedix OHK Medical Devices Virtual Ports
Industrual OEM Infection Control and Infectious Diseases
Albaad Noam Urim Enterprises Albaad Beth-El Industreis Hyginex Mizra Medical NanoVibronix Noam Urim Enterprises Sion Biotext Medical
Intensive Care
ETView Flight Medical
2011

Category
Company
Laboratory Equipment Medical and Hospital Equipment
DYN Diagnostics Aerotel Beth-El Industreis Biovo Technologies Coolsense Discover Medical Devices DYN Diagnostics EarlySense Erika Carmel Estar Medical ETView Flight Medical FlowSense Hyginex HypnoCore IceCure Intromedix Kapel-Kal Medigus Motorica NanoVibronix OHK Medical Devices Polytex Technologies Q Core Medical Sialo Technology Tav Tech Ltd Ultra Rhino-Therm Virtual Ports Xenolith Medical
Monitoring
Cnoga EarlySense Elitar Medical FlowSense Hyginex HypnoCore Vasa Applied Technologies
2011

Category
Company
Neurology and Degenerative Disease
Coolsense Medoc Motorica Itamar Medical
Pharmaceuticals Respiratory and Pulmonary
Gilco Pharm Discover Medical Devices ETView Itamar Medical Flight Medical HypnoCore
Rehabilitation
Erika Carmel Itamar Medical Motorica
Robotics
DYN Diagnostics Flight Medical Motorica
Services Telemedicine and Healthcare IT
2P2D Solutions Arazy Group 2P2D Solutions Elitar Medical HypnoCore Shina Systems
Urology
Mizra Medical NanoVibronix Vasa Applied Technologies Xenolith Medical
Wound and Pain Management
Erika Carmel Gilco Pharm Medoc NanoVibronix Sion Biotext Medical
2011
Table of Contents (by alphabetical order)

Page
Company
Category
2P2D SOLUTIONS
Telemedicine and Helathcare IT Services
14
15
3QBD
Diagnostics
16
Aerotel
General Health Medical and Hospital Equipment Disposables and Implantable General Health
Albaad
17
Industrial OEM Infection Control and Infectious Diseases
18
Arazy Group
Services
Beth-El Industries
Medical and Hospital Equipment Infection Control and Infectious Diseases
19
E.M.S General Surgery Biovo Technologies
Medical and Hospital Equipment Disposables and Implantable
20
21
BSP Biological Signal Processing
Diagnostics Cardiovascular and Peripheral Vascular
2011

Page
Company
Category
Monitoring
22
Cardiovascular and Peripheral Vascular Cnoga Diagnostics General Health Aesthetics and Dermatology Medical and Hospital Equipment
23
CoolSense Medical
Aesthetics and Dermatology General Health Neurology and Degenerative Diseases Medical and Hospital Equipment Respiratory and Pulmonary Diagnostics
24
Discover Medical Devices
25
DYN Diagnostics
Robotics Laboratory Equipment Medical and Hospital Equipment
26
EarlySense
Monitoring General Health Diagnostics Monitoring
27
Elitar Medical
Telemedicine and Healthcare IT Cardiovascular and Peripheral Vascular General Health Aesthetics and Dermatology
28
Erika Carmel Ltd.
Wound and Pain Management Medical and Hospital Equipment Rehabilitation
2011

Page
Company
Category
29
Estar Medical
Medical and hospital Equipment
Disposables and Implantable Intensive Care
30
ETView
General Surgery Respiratory and Pulmonary E.M.S Medical and Hospital Equipment Disposables and Implantable E.M.S Medical and Hospital Equipment Rehabilitation
31
First Care Products
32
Flight Medical
Intensive Care Respiratory and Pulmonary E.M.S
33
FlowSense
Monitoring Medical and Hospital Equipment Pharmaceuticals
34
Gilco Pharm
Aesthetics and Dermatology E.M.S Wound and Pain Management
2011

Page
Company
Category
Monitoring
35
Hyginex
Infection Control and Infectious Diseases Medical and Hospital Equipment Diagnostics Medical and Hospital Equipment
36
HypnoCore
Monitoring Telemedicine and Helathcare IT Cardiovascular and Peripheral Vascular Respiratory and Pulmonary
37
IceCure
Medical and Hospital Equipment
38
Intromedix
Medical and Hospital Equipment General Surgery Diagnostics Cardiovascular and Peripheral Vascular
39
Itamar Medical
General Health Neurology and Degenerative Diseases Respiratory and Pulmonary
40
Kapel - kal
41
Medigus
Return to Table of Content 10
2011

Page
Company
Category
Diagnostics
42
Medoc
Neurology and Degenerative Diseases Wound and Pain Management Disposables and Implantable
43
Mizra Medical
Urology General Health Infection Control and Infectious Diseases Medical and Hospital Equipment Robotics
44
Motorika Medical
Rehabilitation Neurology and Degenerative Diseases General Health Urology
45
NanoVibronix
Wound and Pain Management Infection Control and Infectious Diseases Medical and Hospital Equipment
46
Nava Group
Disposables and Implantable General Health
47
Noam Urim Enterprises
Industrial OEM General Health Infection Control and Infectious Diseases
2011

Page
Company
Category
48
OHK Medical Devices
General Surgery Disposables and Implantable
49
Polytex Technologies
50
Q Core Medical
51
Shina Systems
Telemedicine and Healthcare IT Cardiovascular and Peripheral Vascular Medical and Hospital Equipment
52
Sialo Technology
Diagnostics Disposables and implantable Disposables and Implantable
53
Sion Biotex Medical
Cardiovascular and Peripheral Vascular Wound and Pain Management Infection Control and Infectious Diseases Medical and Hospital Equipment Aesthetics and Dermatology
54
TavTech Ltd
55
Toefix
Disposables and implantable
2011

Page
Company
Category
56
Ultra Rhino-Therm
57
Vasa Applied Technologies
Monitoring Diagnostic Urology
58
Virtual Ports
Medical and Hospital Equipment General Surgery
59
Xenolith Medical
Urology Medical and Hosiptal Equipment
2011
2P2D SOLUTIONS
Category: Telemedicine and Healthcare IT Services
www.2p2d.com
Company at a Glance
2P2D Solutions Ltd. is a pioneering technology-based company developing unique solutions for various unmet needs within the healthcare, biotech and pharmaceutical industries. 2P2D Solutions Ltd. has developed a breakthrough automated drug monitoring system for use in clinical drug trials that incorporates a portable, personalized medication dispensing device using proprietary 2P2D technology.
Company Status: Complete Validation Study
Technology and Product(s)

2P2D Solutions Ltd. has developed ClinicAid, a breakthrough automated drug monitoring system that incorporates a portable medication dispensing device using proprietary 2P2D technology. The system dispenses personalized drug dosages designated for each specific patient or group of patients. After patient identification has been fully authorized, according to the designated clinical trial treatment regimen. This exclusive medication management system, for use in clinical drug trials, ensures unequaled compliance, accountability and accuracy. The Companys telemedicine solution provides: Complete and real-time knowledge of the participants compliance and adherence to the trial protocols. Reduced overall duration of the clinical trial period. Increased participants compliance and adherence to the given medication. Cost effective solution for clinical trial packaging and drug accountability.
Goal
Objectives: Investment, Strategic Alliances Target Businesses: CROs, Pharma companies, Hospitals Target Countries: Worldwide
2011
3QBD
Category: Diagnostics
www.3qbd.com
Company at a Glance
Located in Arad, Israel, 3QBD Ltd. is an ISO certified start up medical device company. The company has developed the VGTest, is an In-Vitro Molecular Diagnostic (IVD) device based on Ion Mobility Spectrometry (IMS) which is used currently for detection of Vaginal Discharge Infections (VDI). In December 2009 3QBD Ltd. received the European CE mark for the VGTest, a device capable of detecting and provides a positive/negative indication for Bacterial Vaginosis (BV), the most prevalent womens vaginal infection within 60 seconds. Future development plans for 3QBD include further research into the VDI field, to detect additional infections and expanding to other diseases like STD and Cancer, to offer rapid, accurate results. Further expending to other markets like food and livestock.

IMS (Ion Mobility Spectrometry) Technology 3QBDs technology is based on the well established and scientifically proven Ion Mobility Spectrometry (IMS) technology first used successfully to detect drugs and explosives. Today IMS is being used to detect presence and type of infection. Chemical changes in living systems, or degradation of cells after death through enzymatic and microbial processes, are accompanied by the breakdown of amino-acids and production of biogenic amines. Pathological conditions in the human body may be expressed in the formation of biogenic amines, so that elevated levels of biogenic amines may be indicative of dysfunctions. IMS is a sensitive instrumental technique for detecting volatile compounds. It is based on measuring the velocity of ions (ion mobility) drifting through a gas bath under the influence of an electric field. The Product The device works by measuring biogenic amines that are present at elevated levels in infections and diseases and provides a rapid and accurate indication. In the case of the BV the result is provided within one minute. The VGTest for BV spares the physician from having to perform the Amsel Test and whiff tests of vaginal fluid or spend time waiting for laboratory Gram Stain results
Goal
Objectives: Distribution for BV, Strategic allaincess, R&D Funding Target Businesses: Womens Health professionals, gynecologists, obstetricians, hospitals and health clinics Target Countries: Worldwide
2011
Aerotel
Category: General Health Medical and Hospital Equipment
www.aerotel.co.il
Company at a Glance
Aerotel is one of Israels longest established high tech companies, specializing in the manufacturing of communication and medical devices. Aerotel is known for being the first company in Israel to develop an interactive voice response (IVR) system as well as the portable Hi-Pack ECG gauge. The company has exported its products internationally to approximately 40 countries. Its large and diverse customer base includes leading multinational corporations such as AT&T. The innovative MDwave system is a revolutionary development in the frequency therapy field which brings new hope to patients who have been unable to treat themselves by means of conventional medicine. Based on extensive experience in offering individualized personal service to patients, Aerotel has designed the MDwave to provide maximum flexibility and efficiency to meet each patients distinctive requirements. Aerotel experts are continually working to include the latest Frequency Medicine knowhow, in the MDwave system. This product has been developed over an eight-year period and is complaint with the following standards: FCC and CE 60601-1 and 2.
Company Status: Clinical Trials

Aerotel Ltd. has developed a breakthrough medical device, known as MDwave, which restores energy levels and treats chronic and acute conditions through the use of Frequency Medicine. Recent studies have demonstrated the positive effect of a low strength electromagnetic field in specific frequencies, on various systems of our body, demonstrating high efficacy of such treatments. MDwave is based on creating a low electromagnetic field that impacts the human cell properties under health and diseased conditions. This field delivers a safe electromagnetic energy to the human cells, which encourages them to return to proper and balanced function, and to operate in a healthy and harmonious way. This enables the immune system to improve its ability to withstand the daily battle against energy-sapping pollutants, hence increasing the bodys ability to heal itself. MDwave is a completely safe, compact and easy-to-use device for administering Frequency Medicine therapy, via an Electromagnetic field. To get started, you simply connect the MDwave to a computer and choose from an extensive list of treatments the desired routine for your patient. Once the treatment routine is set, the MDwave operates without a computer.
Goal
Objectives: Searching for distributors Target Businesses: Distributors Target Countries: Worldwide
2011
Albaad
Category: Disposables and Implantable General Health Industrial OEM Infection Control and Infectious Diseases
www.albaad.com
Company at a Glance
Albaad is one of the three leading producers of wipes worldwide. As a fully integrated converter with production facilities in Germany, US and Israel, global R&D, regulatory suport and engineering teams, Albaad is a preferred contract manufacturing partner for renowned multinationals and retailers. We dont just make wet wipes; we make it our business to know everything there is to know about them, constantly studying customer needs, market trends and technological innovations.

Albaad has registered a range of products intended for professional and consumer healthcare use. Our disinfection products are registered as medical device class 2a (FDA and EPA where applicable). Production is also ISO 13485 certified. The range includes several surface and medical device disinfectants, hand hygiene, patient care and bathing kits, adult incontinence wipes and several consumer solutions including natural fever relief, jellyfish relief, hemorrhoids relief and antiseptic wipes. Albaad wipes are one-step ready for use wipes, tailored to meet our customers special needs and requirements. They are made with soft fabrics and impregnated with gentle yet effective liquids. The wipes are produced and tested according to stringent standards and inspected by strict quality assurance procedures.
Company Status: Initial Revenues
Goal
Objectives: Seeking disinfection liquid customers who wish to find a wipe expert partner to expand their line with wipes in Europe. Seeking Private Label manufacturing opportunities for Healthcare distributors in the EU and worldwide. Target Businesses: Institutional distributors, disinfection brands and consumer healthcare brands Target Countries: EU, worldwide
2011
Arazy Group
Category: Services
www.arazygroup.com
Company at a Glance
The Arazy Group expertise is regulatory affairs and quality assurance for the medical device industry. Arazy Group offers medical device registration services in more than 53 countries and have gained market clearance for medical devices and IVDs in North and South America, most European countries, various Asian markets, MENA, Africa and Australia. We implement advance global regulatory products that enable our client to overcome the traditional; multiple-country regulatory compliance that is currently achieved through multiplesubmission processes. For more than 16 years, our professional consultants have utilized validation, verification and regulation processes on a diverse portfolio of medical devices, and are responsible for thousands of successful registrations globally. Our customized solutions accommodate all stages of medical devices life cycle and our adaptable services fit any application and any size organization. We Expedite Success of Safe Medical Devices.
Company Status: Revenue Growth

GlobaR One World Process Traditionally, multiple-country regulatory compliance is achieved through multiplesubmission processes. The common practice is fragmented, inefficient, costly and time consuming. GlobaR regulatory intelligence system generates unique Global Master Regulatory File for any medical device called a GlobaR dossier. The following registration process is quick and efficient since this single file complies with international harmonized standards, local standards and manufacturing quality management system, creating one universal dossier which shows your device is safe and effective. Whether you are seeking enter your device into one market or multiple markets, we have the solution Our experts are often outsourced for quality and regulatory (QA/RA) positions to design and implement regulatory strategy for some of the most advanced and complex devices. Our past experiences comprise of successful registrations of various medical device categories such as, Drug Delivery, Imaging and Navigation systems, Diagnostic Software Energy emitting technology, Therapeutic Devices, Combination Devices, Active and Passive Implants, Diabetic Products, IVDs, Surgical Disposables, Dental Implants and Dental Lab Products.
Goal
Objectives: Increase client base and locating local agent in additional countries. Target Businesses: Medical device manufactureres, regulatory affairs consultants and R&D companies Target Countries: Worldwide
2011
Beth-El Industries
Category: Medical and Hospital Equipment Infection Control and Infectious Diseases E.M.S General Surgery
www.beind.com
Company at a Glance
Beth-El Industries is a leading developer and manufacturer of medical negative pressure isolation systems and collective NBC filtration systems. Drawing on more than 30 years of experience in the air filtration field, Beth El Industries Ltd. now offers the medical market an array of stationary and portable Isolation Chambers, Clean Rooms and stand-alone Air Filtration Systems for applications in hospitals and ground or airborne ambulances. Beth-Els IsoArk isolation chambers are designed to quarantine infected people and protect the outside enviroment from contagious diseases like SARS, Ebola and TB. A unique series of products was developed and are now used by International Disaster Relief organization in difficult environments worldwide. Our main features: Quick and effective isolation Simple and fast assembly with no additional tools Portable solution can be brought to the problem Variety of sizes and custom manufacturing according to our clients requests Costs only a fraction of the price of a permanent stationary isolation rooms. Beth-El Zikhron Yaaqov Industries Ltd. is certified for ISO 9001:2000, AQAP-2110 and AS 9100 quality management systems and is audited regularly by external entities.

IsoArk - portable, negative pressure chamber designed for a rapid set up of a biologically isolated environment, for a quick and effective isolation of contagious people and equipment. The system includes an airlock attached to the main chamber, an air filtration system and special features that enable to treat the patient from the outside, avoiding contamination of equipment and staff. All components of the system meet and exceed todays standards for infection isolation. IsoArk N36-4 - portable isolation chamber for transport of a single person in biological isolation. Designed specifically for the unique requirements and confided spaces of ambulances and helicopters, this new product incorporates both Isolation Chamber and Clean Room features, cleaning both the incoming and the outgoing air. Either positive or negative air pressure can be created inside the chamber, according to the users needs. With the battery fully charged, the system can operate for up to 10 hours independently of external power source and guaranties a complete isolation of the space inside the chamber during transport. The collapsible, lightweight structure allows for a quick set up of the system and minimal storage requirements when not in use.
Goal
Objectives: Agent able to promote our products in the medical and emergency prepardness sectors in his country Contact with potential end customers. Target Businesses: Government agencies in charge of emergency prepardness, hospitals, importers and distributors of medical equipment, ministry of health, ambulance and ambulance equipment companies, airports. Target Countries: Worldwide
2011
Biovo Technologies
Category: Medical and Hospital Equipment Disposables and Implantable
admin@biovo.net
Company at a Glance
Biovo develops breakthrough products for hospital intensive care (ICU). Our products aim to provide highly effective patient care, with less nurse work effort, and reduce VAP risk.
Technology & Product(s)

Breakthrough products for hospital intensive care (ICU): (1) AirVent - Effective ETT biofilm cleaning integrated in a closed suction system. Biofilm buildup clogs ETT tubes, increase risk of VAP and decrease air patency of the ETT lumen. The AirVent Closed Suction System incorporates new lumen cleaning capabilities combination with conventional suction action within the familiar closed suction framework. (2) PoliVent VAP infection prevention with novel non-inflatable self-expanding cuff of Endo-tracheal tubes. All present ETT inflatable cuff balloon systems fail to effectively prevent leak of infected oral fluids considered the primary source of VAP infection in ICU. All present ETT cuff pressure is unstable require repeated adjustments by ICU nurse. For the first time, the Poliventreplace the balloon with a new fluids blocking cuff system. The PoliVent ETT cuff is self-expanding with no need of air inflation and no need of repeated pressure monitoring and adjustment by the ICU nurse, and providing continuous stable blocking of infected fluids leak.
Company Status: Pre-Clinical
Goal
Objectives: Identify relevant and interested distribution partners & manufacturing partners Target Businesses: Medical device distribution company with presence in Intensive Care Units Target Countries: Europe (primary); U.S. and Asia (secondary)
2011
BSP Biological Signal Processing

Category: Diagnostics Cardiovascular and Peripheral Vascular
www.bspmedical.com
Company at a Glance
Founded in 2000, BSP Biological Signal Processing Ltd. is a medical device company with corporate offices in Tel Aviv, Israel and a US subsidiary BSP Inc. in Boston, MA. BSP is publicly traded on the Tel Aviv Stock Exchange since 2006 (TASE:BSP). BSP develops and commercializes a new generation of systems for non invasive diagnosis and monitoring of Coronary Artery Disease (CAD), based on advanced signal processing of the ECG signal which integrates the Companys unique, patented, HyperQ technology.

BSP has pioneered the clinical implementation of high-frequency ECG and has developed it into a fast, accurate, low-cost, simple to operate and non-radiating technology for detecting CAD with greater clinical value than the current standard ECG. The companys proprietary HyperQ technology extracts and analyses the high-frequency components of the ECG and provides a unique diagnostic index. Thousands of patients have been tested with the HyperQ system to date, demonstrating consistently that HyperQ is far superior to conventional ECG both in sensitivity and specificity, with the potential to save up to 50% of the unnecessary radioactive imaging procedures, while improving the standard of care. BSPs Intellectual Property portfolio is backed by four granted patents and 14 filed applications in different stages. HyperQ EX-300: The worlds first advanced system incorporating conventional stress ECG and the revolutionary highly accurate HyperQ CAD diagnosis in a single, small footprint unit. This system is FDA (510k) cleared and CE marked. HyperQ AD-100: Seamlessly integrating the highly accurate HyperQ CAD diagnosis into the existing workflow, HyperQ AD-100 is an add-on to standard stress ECG systems, enhancing conventional ECG results. This system is FDA (510k) cleared and CE marked.
Goal
Objectives: The Companys primary strategic objectives include establishing HyperQ as the first line modality for monitoring and diagnosis of CAD in cardiology clinics, ambulatory and hospital settings and attaining reimbursement code and premium coverage over competitors for the HyperQ diagnostic modality in the US. Growth in market penetration and market share will be achieved through a combination of business partnerships with equipment and healthcare service providers, and by the establishment of a global marketing and sales presence. Target Businesses: Distributors specializing in cardiovascular diagnostic devices, leading manufacturers in the field of cardiovascular diagnostic devices for potential business partnerships, leading health service providers. Target Countries: Worldwide
2011
Cnoga Medical
Category: Monitoring Cardiovascular and Peripheral Vascular Diagnostics General Health Aesthetics and Dermatology
www.cnoga.com
Company at a Glance
Cnoga Medical is an innovative developer of easy-to-use, touch free and non-invasive medical devices. It is Cnogas belief that the time is soon approaching when most blood tests will be conducted by the patients themselves, in the comfort of their own homes, and with a simple non-invasive device.

CNOGA Medicals technology provides a new patent pending and state of the art solution for the non-invasive / touch free methods of measuring physiological parameters. CNOGAs technology is based on real-time tissue photography, tissue image color is being processed in real-time, providing the temporarily color distribution, using dynamic range of at least 36 color-depth representing over 6.8^10 color combination then by using sophisticated mathematical algorithm, the vast amount of information is being computed and analyzed for detecting the correlation between temporarily color pigmentation and a specific bio or physiological parameter. Products: The TensorTip VSM Pulse rate, Blood Pressure and SpO2 monitoring device The Hemoximeter Hemoglobin, Pulse rate, SpO2 monitoring device The Glucometer Blood glucose, non-invasive, monitoring device
Goal
Objectives: Meet potential business partners and distributors as well as potential customers Target Businesses: Medical Device Distributors, hospitals and medical insurance companies Target Countries: Global
2011
CoolSense Medical
Category: Medical and Hospital Equipment Aesthetics and Dermatology General Health Neurology and Degenerative Diseases
www.coolsense.net
Company at a Glance
COOLSENSE Medical Ltd. is a subsidiary of the M.D. Clinic Group based in Tel-Aviv, Israel; an established and prestigious medical health center whose specialty in non-surgical aesthetic procedures serve an extensive network of cosmetic treatment clinics. CoolSense Medical Ltd. was responsible for the R&D that preceded the manufacture of the innovative hand-held CoolSense pain numbing applicator. CoolSenses successfully implemented concept offers medical personnel, aestheticians and the general public a revolutionary but simply operated instrument that eliminates the pain and discomfort of injection procedures. CoolSense Pain Numbing Applicator which received CE approval, FDA Certification as well as the Israeli Certificate of Free Sale is in use worldwide. CoolSense Medical intends launching MIGROCALM during Medica 2011. MIGROCALM is an innovative self-regulated therapeutic device for the emergency relief of severe migraine type head pain.

The innovative CoolSense device, when applied to the skin immediately anesthetizes the site of injection with no after effects. The CoolSense Pain-Free Injection Applicator has been accepted as an indispensable instrument for health care personnel when performing medical or cosmetic skin invasive procedures. The CoolSense Applicator is also an invaluable tool that greatly improves the quality of life for individuals who are obliged to undergo injection procedures on a daily basis. CoolSense acts within 3-5 seconds to do away with the stress and fear that is associated with receiving injections, the most common health-care procedure worldwide. The MIGROCALM - An innovative self-regulated therapeutic device for the emergency relief of severe migraine type head pain. MIGROCALM has been designed for personal use in the home; offers drug-free, noninvasive and highly effective relief of severe migraine associated head pain.
Goal
Objectives: Finding potential distributors for main European and Latin American countries Target Businesses: Distributors Target Countries: Germany, France, Switzerland, UK, Latin America.
2011
Discover Medical Devices

Category: Medical and Hospital Equipment Respiratory and Pulmonary
www.discovermedical.com
Company at a Glance
Discover Medical Devices (DMD) has developed a revolutionary new Continuous Positive Air Pressure (CPAP) interface the SomnuSeal masks line for Obstructive Sleep Apnea (OSA). Patients quickly adjust to the comfortable self-adaptable oral mask, solving the markets greatest problem how to increase the low compliance rates for CPAP treatments. This is an unmet need and DMD is the first to successfully address it. DMD makes it possible for the market, with its well established distribution, sales and reimbursement infrastructure, to grow from $3B and reach its full $30B potential. SomnuSeal benefit for a strategic partner: Will increase worldwide market by >3b$/yr Answers an unmet need (no current competition) Perceived Innovative and Leading edge technology. Will provide a massive competitive advantage and locking in of the newly acquired market share of non compliant patients
Company Status: Clinical Trials

Approximately 5% of the population requires CPAP treatment for OSA, including more than 15 million people in the US and 350 million more around the world. DMD designed the revolutionary SomnuSeal masks from the ground up to solve the most serious problem in the OSA market today despite the dangers of OSA, roughly 50% of diagnosed patients stop their CPAP treatment because they cannot sleep comfortably with the cumbersome masks that exist today. In contrast to available traditional masks, DMDs solution (the SomnuSeal masks line) uses the natural oral cavity anatomy to create the seal required for effective CPAP treatment. This innovative development makes it very easy for patients to quickly adjust to the DMD small self-adaptable mask, which does not occupy external facial structures, does not contact sensitive internal oral structures, and does not create any of the side effects that are typical of existing devices. The SomnuSeal is the first and only mask that addresses the non compliant patient market segment successfully.
Goal
Objectives: To establish distribution network Target Businesses: Distributors that are experienced and successful in sales to sleep apnea patients Target Countries: Worldwide
2011
DYN Diagnostics
Category: Diagnostics Robotics Laboratory Equipment
www.dyn.co.il
Company at a Glance
Dyn Diagnostics Inc. is engaged in marketing, sales and support scientific and engineering field tests of body fluids IVD - (In Vitro Diagnostics) and in research laboratories (Applied Science). Dyn Diagnostics was founded in 1990 and since its inception some twenty years ago, is the exclusive representative in Israel of Roche Diagnostics, which is the worlds largest and leading company in the IVD field. The company completes its product line in which Roche is inactive by representing leading companies such as - (Horiba ABX, Grifols, Aesku.Diagnostics etc.), wide product range allows the perfect offering and comprehensive solutions in the field of diagnostics. Dyn Diagnostics is working to implement technologies, innovative processes and advanced testing of human body fluids in the various performance sites. The companys activity is based on a foundation of over a hundred employees with a broad education and skills such as - biological sciences and engineering, information systems, distribution and logistics as well as on experience and knowledge accumulated in the last twenty years.

DYN DS Decapper, Sorter and Archiver The DYN DS is a primary sample decapper/sorter and archiver that is built to efficiencies. The DYN DS decaps different types of closures on standard primary sample tube sizes and automatically sorts up to 1,000 tubes per hour. Tubes are sorted for any laboratory analyzer or target and then finally for archiving. Genotype DNA marker kits We at Dyn market commercial vegetable DNA marker tests. We have been marketing DNA marker test kits, and services locally, for more than 3 years, to all major local vegetable breeders\seed companies. Our customers use our test either as a DNA marker selection tool to assist breeders, or as a post control tool to confirm seed production purity.
Goal
Objectives: Establish Joint Ventures; Find Business Partner that would like to represent our products in various countries; Establish business reletaions with international Medical Device companies looking to enter the Israeli market. Target Businesses: Distributors Target Countries: Worldwide
2011
EarlySense
Category: Medical and Hospital Equipment Monitoring General Health
www.earlysense.com
Company at a Glance
EarlySense is bringing to the market an innovative contact-free patient supervision technology. EarlySenses continuous early sensing capabilities and patient management tools empower the medical staff in the unmonitored units to improve clinical outcomes and reduce pressure ulcers and patient falls by measuring key parameters through a sensor places underneath the patients mattress. The continuous patient supervision device that follows and documents patients vital signs and movement, allows nursing staff to proactively reduce adverse events. EarlySenses system bridges the critical time gap between patient deterioration and clinician intervention. In light of the Joint Commissions 2009 Patient Safety Goals for healthcare organizations, EarlySenses technology offers a timely solution for detecting changes in a patients condition, while also assisting nurses to focus on the patients who need their immediate attention.

EarlySenses technology has three main components: 1. A unique single plate sensing unit 2. A bedside monitor that processes and displays the measured data; and 3. A Central Display Station that enables complete coverage of a unit wide set of monitors at the nurses station and the different alerts are delivered to the nurses handheld devices. The systems built-in management tools include a wide range of reports on the status of patients at all times and can be printed for documentation and clinician analysis. Once placed under a bed mattress, the sensing unit immediately self-activates when sensing the patient in bed. The system is FDA cleared and CE approved and has been shown to improve clinical outcomes in general care units.
Goal
Objectives: To be a market leader in the Medical Supervision Field Target Businesses: Sales in USA, Major Clinical study in Harvard/leading university Target Countries: US, Europe
2011
Elitar Medical
Category: Diagnostics Monitoring Telemedicine and Healthcare IT Cardiovascular and Peripheral Vascular General Health
www.elitr.com
Company at a Glance
Elitar Medical is a medical device company founded in Israel in 2005. The companys mission is to offer a full range of non-invasive, multi-parameter patient monitoring devices and health management software tools to the full satisfaction of its customers and endusers. Elitar stations can be used for preventive screening for emergency room of national hospitals. Elitar develops and manufactures distinct and innovative products hardware and software. The companys unique approach encourages the adoption of a preventative medicine and healthy lifestyle by simplifying the diagnosis and implementation processes by health stations, both of the individual and for the accompanying professionals.

Elitar provides: health station, specially designed to meet the needs of individuals and organizations that either wish to cut down their costs (e.g., hospitals and retirement homes), to increase their profits (e.g., pharmacy chains and gyms), or to improve their health and nutrition management. The health station provide gold standard measurement some or all of the following vital signs: height, weight, BMI (Body Mass Index), RMR (Resting Metabolic Rate),hand grip strength test, body composition, blood pressure, pulse rate, electrical activity of the heart (EKG), heart rhythm regularity oxygen saturation, body temperature all through a quick, non-invasive, single-posture process. In addition, they can be complemented by external monitoring devices. Elitars health station is automatically subscribed to the complementary health and weight management software BioFat and can be subscribed to Telehealth CheckUp, Elitars most advanced health station model, also includes video-conferencing any other external database, including electronic medical records (EMRs) and other telecommunications features, and can be also compatible with the medical magnetic or smart card.
Goal
Objectives: To establish distribution network worldwide, joint-ventures with customers or distributors of diagnostic devices, health insurance companies Target Businesses: Hospitals, private clinics, medical devices distributors, health spa channels, pharmacies Target Countries: Europe, Asia, North Africa, Middle East
2011
Erika Carmel Ltd.

Category: Wound and Pain Management Aesthetics and Dermatology Rehabilitation Medical and Hospital Equipment
www.gd-energies.com
Company at a Glance
As a company whose goal is to bring innovations in treatment, care, and quality of life to more and more people, we are proud to present you with cutting edge technology in soft Laser Therapy: B-Cure Laser is the worlds first portable soft Laser medical device WITH THE HEALING POWER OF A CLINIC. B-CURE Laser is recommended by the best leading specialists and is used widely in Israel by the leading pain clinics, wound healing clinics, and orthopedic departments in the following hospitals: Hadassah-Jerusalem, Sourasky, Rambam, and Shiba (Tel Hashomer). It is also used in physiotherapy clinics of Israeli Defense Forces, leading sports clubs, and the best sportsmen in Israel, as well as by thousands of individuals for self-treatment at home. On January 2010 B-Cure Laser received the European CE 0120 approval for 16 indications and is presently being exported to some European countries. CE 0120 approved indications for the B-Cure Laser are: knee pain, neck pain, pain in lower and upper back, sports injuries, muscle pain, arthritis, fibromyalgia, tennis elbow, achilles tendonitis, carpal tunnel syndrome, inflammation, wound healing, burns, fresh surgical scars, post-pregnancy stretch marks, acne, herpes simplex, dental medicine, acupuncture.

B-Cure Laser - LLLT 808 - Low Level Laser Treatment The soft-laser affects the skins surface and simultaneously penetrates the skin without heating or hurting the skin. Soft laser treatment biostimulates the bodys natural healing mechanism on a cellular and systemic level. The result: every kind of cell receives the energy required for activating and enabling optimal functioning in the body, thus allowing it to self-heal and naturally overcome specific problems. B-CURE LASER - an international breakthrough in soft-laser therapy for professional and personal treatment of the above mentioned indications. Thanks to an exclusive, patent-pending development, we have created an exceptional combination: the power and full coherence of a clinics soft-laser device over a large area of 4.5 cm, with a portable, rechargeable, safe and easy-to-use device all at a reasonable price. The result: a perfect combination of the most effective therapy with the ability to provide immediate and continuous treatments, thus enabling high quality and fast recovery in shorter individual treatment times, and with less total healing time. OUR INNOVATION FOR MEDICA 2011: B-CURE LASER PROFESSIONAL.
Goal
Objectives: Distribution Target Businesses: End-users for self-treatments at home, Pharmacies-a unique business model, Clinics, Hospitals, Sports teams, Athletes, Security forces, Home care, Nursing homes.
Target Countries: EU, USA, South America, Australia
2011
Estar Medical
Category: Medical and Hospital Equipment
www.estar-medical.com
Company at a Glance
Estar Medical develops, produces and markets a wide range of superior medical products for healthcare professionals and laboratories. Estars main areas of activity are: Assisted Reproduction Technologies (A.R.T) Israels No. 1 expert and distributor of A.R.T products, being a one-stop-shop for establishing fertility labs and providing innovative turn-key solutions in Israel and abroad. Estar continuously upgrades and enhances its product portfolio with state-of-the-art products from the leading companies, such as in the pioneering fields of In Vitro Maturation (IVM) and Vitrification. Regenerative Medicine in-house development of TropoCells Platelet Preparation System for the separation of platelet concentrates from the patients own blood. The TropoCells product line provides creative solutions for a wide range of applications and users. Estars goal is to develop unique products isolated from autologous peripheral blood, based on its core competencies in blood collection and separation. Vacuum-based blood & urine collection - Estar Medical was among the world pioneers in this field.

The TropoCells Platelet Preparation System based on Estars proprietary technology - is designed to concentrate platelets with their associated growth factors from the patients own blood. Estar Medical provides a wide range of solutions for Sports Medicine, Plastic Surgery, Chronic Wounds, Dentistry and Veterinary Medicine. The TropoCells platform technology enables easy adjustments to an ever growing range of medical applications, as well as offering tailor-made solutions for specific requirements. The unique design of TropoCells enables: High yield of platelets with available growth factors Time-saving - only one centrifugation is required Easy handling and processing Efficient collection of the platelet concentrate utilizing the TropoCells proprietary Filtering Sleeve Filtering WBC types out of the platelet concentrate using the TropoCells Filtering Sleeve (optional) Preparation in doctors office Maximum modularity & flexibility - easy adjustment to different varieties of applications and users Products are CE marked, FDA cleared and manufactured in compliance with Quality Standards EN ISO 13485:2003 and ISO 9001:2008
Goal
Objectives: Seeking partners/distributors for the TropoCells Platelet Preparation System product line Target Countries: World-wide
2011
ETView
Category: Disposables and Implantable Intensive Care General Surgery Respiratory and Pulmonary E.M.S Medical and Hospital Equipment
www.etview.com
Company at a Glance
ETView is a commercial stage, publicly traded medical device company focused on combining airway management with continuous direct visualization for multiple thoracic surgical procedures as well as long term ventilator dependent patients. ETView manufactures the Tracheoscopic Ventilation Tube (TVT), an endotracheal tube fitted with a camera and a light source. TVT combines high-flow ventilation, airway management and continuous video monitoring to overcome current limitations and associated adverse surgical procedure events during lung isolation surgeries as well as managing and limiting potential surgical injuries resulting from percutaneous tracheotomy and anticipated difficult intubations. The TVT is also sold as a trainer, and is the ideal device for teaching and refreshing intubation skills to medical students, anesthesiology residents and emergency personnel.

ETViews patented single-use tracheoscopic ventilation tube (TVT) incorporates a video camera and light sourc embedded in the tip of an endotracheal tube. The images from the TVT can be viewed on ETViews dedicated monitors, or on other hospital medical monitors. With a camera at this critical location, medical personnel can effectively monitor surgical procedures such as the placement of endo-bronchial blockers in lung isolation procedures and the performance of percutaneous tracheotomy in long term ventilated patients in the ICU as well as constantly monitor the endotracheal tube tips position in such patient groups. The TVT is indicated for use in the OR and ICU.
Goal
Objectives: To find distributors which will sell the TVT in their respective markets Target Businesses: Distributors Target Countries: Worldwide
2011
First Care Products

Category: Disposables and Implantable E.M.S
www.firstcareproducts.com
Company at a Glance
First Care Products specializes in the development and marketing of new products for prehospital emergency medical situations. The companys mission is to provide intelligent, innovative, effective and simple to use products which assist in life-saving, improve the treatment provided and yield significant savings in time and resources. Save One Life, Save A World Active in medical R&D, the company develops beneficial solutions for pre-hospital medical emergencies. First Care Products provides medics, first responders and the injured themselves with easy and quick to use, effective products for the control of hemmorhage resulting from trauma that save lives and greatly boost the treatment provided whether on the battlefield, homefront or accident scene. The company brings its years of comprehensive R&D and field experience to create products that when every second counts make the difference between life and tragedy.

The Emergency Bandage First Care Products first and flagship product, The Emergency Bandage in all its versions has been designated as the STANDARD Personal Field Dressing by numerous major, quality military organizations and is being utilized by Special Forces and military medical corps worldwide. The Emergency Bandage is combat and clinically proven, being relied upon as an integral and vital component in the treatment of hemorrhage and trauma related injuries. Beyond Military Use In addition to militaries around the world, First Care Products supplies its innovative bandages to governmental and private emergency medical services, Fire Rescue, Police and Prison Authorities, First-Aid and Survival Academies, and suppliers of first-aid equipment to the general public. Worldwide Patent and Approvals First Care Products bandages are Patented worldwide, FDA and CE Approved, with Health Ministry Approvals in each territory, NATO Reference Numbers, and NSNs in the USA. First Care Products manufactures all its products according to the highest International Standards including ISO 13485.
Goal
Objectives: Strategic Alliances Target Countries: Worldwide
2011
Flight Medical Innovations

Category: Medical and Hospital Equipment Rehabilitation Intensive Care Respiratory and Pulmonary E.M.S
www.flight-medical.com
Company at a Glance
Flight Medical is a leading manufacturer of high end PORTABLE VENTILATORS. The company developed and manufacture the legendary HT50 and sold over 15,000 worldwide. Flight Medical has recently launched the Flight 60 ventilator deploying its proprietary leading edge technology.

The Flight 60 follows the success of more than 15,000 HT50 ventilators deployed worldwide. Flight 60 is an all-purpose ventilator designed to address the growing need for ventilation in Home Care, Long Term Care, Emergency, Transport, Hospital and SubAcute. The newly introduced Flight 60 Ventilator is offering a lot more A Complete Ventilation Suite All Pressure and Volume ventilation modes Actual flow measurements (Vti,Vte) Embedded FiO2 sensor Single limb and dual limb mode Autonomous 12 hours battery life further extended by hot swap Low flow and high pressure oxygen source connection Light weight, portable and robust Intuitive and Easy to Use 7 colored touch screen All ventilation parameters on a single screen Enhanced graphical display Cutting-Edge Dual Micro Piston Technology Top clinical performance Low power and O2 consumption Low heat generation Low cost of ownership
Goal
Objectives: Establish global distribution network. Target Businesses: Distributors of medical devices to Home Care, Hospitals and Long Term Care markets Target Countries: Asia, Americas, Europe, India
2011
FlowSense Ltd.
Category: Medical and hospital Equipment Monitoring
www.flowsensemedical.com
Company at a Glance
FlowSenses product, URINFO 2000, enables physicians to optimize fluid management and acute renal care by automating the monitoring of urine output accurately, continuously, and in real-time.

URINFO 2000 offers automated urine output monitoring for patients in the acute care setting. Today, there is no effective means by which this important marker can be measured and captured reliably, continuously, and in real-time. Urine output, today, is measured with mechanical urine meters which are labor intensive, based on manual volume readings, and do not provide current urine output data. URINFO 2000, enables physicians to optimize fluid management and acute renal care by automating the monitoring of urine output accurately in real-time, continuously. Automated monitoring can result in earlier detection, more rapid intervention, and improved patient outcomes and reduced hospital costs. URINFO 2000 is comprised of a small electronic unit (display and cradle for disposable) installed on the bed and a disposable that connects to any catheter and is proprietary to the URINFO system. The product is in daily use in several hospitals.
Goal
Objectives: Identify relevant and interested distribution partners Target Businesses: Medical device distribution companies with presence in Intensive Care Unit and Operating Room Target Countries: Europe (primary); U.S. and Asia (secondary)
2011
Gilco pharm
Category: Pharmaceuticals Aesthetics and Dermatology E.M.S Wound and Pain Management
www.gilcopharm.com
Company at a Glance
Gilco Pharm is a well established pharmaceutical company that manufactures and markets high quality, innovative, Medical Devices, Medico-Cosmetics and Food Supplements. Our main focus is treatment and prevention in the following fields: Dermatology, Gastroenterology and ENT. From its inception as a family business in 1994, by Pharmacist Mr. Gil Tagger Gilco Pharm has made it its goal is to provide patients with the best possible therapies for a diverse range of needs and help improve their quality of life. Our highly skilled professional team is dedicated to excellence and is committed to staying constantly at the forefront of scientific development as well as keeping a competitive edge, by being highly flexible in todays changing market. Gilco Pharm combines professional and logistical skills in the medical field with good connections in the marketplace. Gilco Pharm implements four ISO systems, including: ISO 9001:2008, ISO 13485:2003, ISO 22716:2007 and ISO 22000:2005.
Company Status: Regulatory Approval

GILCO PHARM focuses on the development and production of products for the following conditions: Dermatology And Wound Care: A wide range of products for the prevention and management of dry skin conditions, atopic dermatitis, acne, wounds and burns. ENT preparations, based on Dead Sea salt, for the management of dry mouth and nose, sore throat and cough. Gastrointestinal Phosphate free ready for enema, fibers syrup and Hemorrhoid gel. Lice Treatment A unique pesticides free preparation and repellent. Personal Lubricants including water base, silicone and warming lotion. Within this line, we also include a long lasting moisturizer and acidifying gel.
Goal
Objectives: Seeking distributors for our products Target Businesses: Distribute our brands or out-lisencing Target Countries: Europoe, USA and Asia
2011
Hyginex
Category: Monitoring Infection Control and Infectious Diseases Medical and Hospital Equipment
www.hyginex.com
Company at a Glance
Hyginex, founded in 2008, brings a new era to hospital hygiene and infection control. Hyginexs technology combines an advanced network of sensors, and an online server to process and display hand hygiene information. The Hyginex breakthrough enables for the first time real monitoring, management and control of the hospital staff hand hygiene protocol compliance and quality. With You Can Control Only What You Can Measure as its motto Hyginexs product enables hospital management to receive simple and detailed reports that describe the hand hygiene compliance and the washing act.

The Hyginex system is a complete wireless hand hygiene monitoring system for healthcare staff monitoring whether they clean their hands when needed and if they do so according to the protocol. The system creates detailed reports from the collected data and provides a simple and flexible user interface for understanding current status and trends of the hand hygiene in the hospital. Constant monitoring increases hand-hygiene compliance with almost no management effort and minimal educational overhead. On-line Real-time alert system enables management to be updated immediately on any deviation from the hospital defined hand hygiene policy. Personal alerting enables workers to receive immediate feedback that enables them to greatly improve their hand hygiene compliance and quality.
Goal
Objectives: System Marketing, Establishment of Distribution partnerships Target Businesses: Distributors Target Countries: Worldwide
2011
HypnoCore
Category: Diagnostics Medical and Hospital Equipment Monitoring Telemedicine and Healthcare IT Cardiovascular and Peripheral Vascular Respiratory and Pulmonary Company Status: Initial Revenues
www.hypnocore.com
Company at a Glance
HypnoCores vision is to become the global leader of sleep diagnostics services, devices, and solutions for the medical and consumer markets. HypnoCore Ltd. aims to revolutionize the field of sleep diagnostics and improvement solutions utilizing web and mobile technologies, medical and consumer devices, to allow accurate and affordable access to sleep diagnostics and health improvement solutions for the consumer and medical markets.

Following over a decade of academic research and years of R&D, HypnoCore Ltd. has developed patented, FDA and CE approved technology that analyzes the strongest and most robust signal, the electrocardiogram (ECG), in order to evaluate sleep and diagnose sleep disorders. Based on its core IP, HypnoCore developed a set of products: HC1000P: HypnoCores flagship product - reliable, automated diagnostic software that relies on ECG and oximetry measurements to evaluate sleep and diagnose sleep related breathing disorders HC1000: Diagnostic software that analyzes ECG data to diagnose insomnia SleepWay: Web-based system for centralized scoring and data management SleepRate: Utilizing the latest sensor technology, internet and mobile technologies, HypnoCore Ltd. is developing a new lineup of consumer products and services under the SleepRate brand
2011
IceCure Medical Ltd.

www.icecure-medical.com
Company at a Glance
IceCure Medical Ltd. (TASE: ICCM) develops and commercializes office-based, minimallyinvasive, Cryoablation platform in the area of Womens Health. One in 4 women in the U.S. is diagnosed with benign tumors in the breast (Fibroadenomas) or the uterus (uterine fibroids). These tumors account for > 700,000 surgeries each year in the U.S. IceCure offers a safe and effective treatment alternative to surgery, that may be performed in the physicians office or in an outpatient facility. IceCure Medical Introduces IceSense3: a minimally invasive, office-based, Cryoablation treatment of breast Fibroadenoma. Clinical studies have shown Cryoablation to be a safe and effective alternative to surgery for treatment of breast Fibroadenoma. Based on these studies, a reimbursement code has been defined for in-office procedures (CPT 19105), and the American Society of Breast Surgeons (ASBS) has issued a consensus statement about the products safety, efficacy and durability. IceSense3 is approved for sale in the US and Europe.

IceSense3 unique technology uses liquid nitrogen for rapid freezing of the lesion. The system, with its intuitive graphical user interface is designed for maximum flexibility and simplicity for a single operator. IceSense3 is compatible with the latest advancements in ultrasound-guided interventions, such as 3D navigation, for a faster and more accurate procedure. IceSense3 is the natural choice for patients and physicians: Excellent cosmetic results - Regardless of fibroadenoma size, the probe is inserted through a 3 mm incision, causing virtually no scar. No tissue is physically removed, hence there is no deformation of the breast, and there is no impact on the shape or appearance of the breast. Quick Procedure - With the IceSense3 rapid cooling technology, treatment takes as little as 5-15 minutes (depending on the size of the treated area), saving precious time. No pain - The freezing has an analgesic effect, so the patient hardly feels anything during treatment. Local anesthesia is used for the insertion of the probe, much like a biopsy procedure. No Downtime - The patient can return to normal activities immediately after the procedure. With IceSense3, the treatment of breast FibroadenoUp-to 1250 Charachters
Goal
Objectives: Establish relationship with potential customers and distributors in Europe for Marketing and sales of the IceSense3.
2011
Intromedix
:Category Disposables and Implantable Medical and Hospital Equipment General Surgery
www.intromedix.com
Company at a glance
Intromedix is an Israeli manufacturer of premium quality, cost- effective, generic, disposable surgical equipment. Intromedix has been certified ISO 13485 and has applied a Quality Management System according to 93/42/EEC. Certification was given by the German Notified Body Medcert.
Technology andProduct(s)*
Surgical sutures - absorbable and non absorbable Surgical staplers Skin staplers Surgical Mesh
Company status: Revenue growth
*All products are certified
Goal
Objectives: Establish global partnership channels for the distribution of our products Target Businesses: Distributors Target countries: All
2011
Itamar Medical
Category: Diagnostics Cardiovascular and Peripheral Vascular General Health Neurology and Degenerative Diseases Respiratory and Pulmonary
www.itamar-medical.com
Company at a Glance
Itamar Medical Ltd., is a public traded (TASE: ITMR) bio-medical technology company. Itamar develops and markets noninvasive diagnostic medical equipment based on proprietary PAT (Peripheral Arterial Tone) Signal. The PAT Signal serves as a noninvasive window to the Cardiovascular and Autonomic Nervous Systems. The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip by specialized noninvasive probes. Itamars FDA cleared and CE marked PAT-based products are: Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial function assessment the precursor (earliest clinically detectable stage) of cardiovascular disease. Watch-PAT200: ambulatory diagnosis of sleep related breathing disorders and sleep staging (Wake/REM/Deep sleep/light sleep stages). Both devices are used in preeminent clinical institutions, research centers and Pharmaceutical clinical phase studies in over 40 countries which have yielded nearly 300 publications.

Sleep testing - at home Considered best in class, WatchPAT (FDA cleared and CE marked) is a wrist mounted device for at-home testing of sleep apneas and sleep staging (REM/Deep Sleep/Light Sleep/Wake stages). WatchPAT also measures snoring and body position and provides a perfect combination of natural sleep at home with sleep-lab level data. WatchPAT works without the multiple cables and electrodes needed by other technologies which provide in-depth analysis of sleep, so it has an incredibly low failure rate. Yet the physician gets a comprehensive report with all the clinical parameters needed for patient treatment and monitoring. While the data is calculated automatically by the WatchPATs software, the physician can easily edit the data too. Noninvasive cardiovascular risk assessment Atherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field of endothelial function assessment, EndoPAT (FDA cleared and CE marked) is used in pre-eminent clinical institutions, research centers and Pharma studies. The noninvasive EndoPAT has been validated by nearly 100 publications and abstracts and provides clinicians with reliable and reproducible results in an office-based, 15 minute test.
Goal
Objectives: Establish wide distribution network in Europe Target Businesses: Distribution Target Countries: Brazil, Germany, UK, Spain, France, China, other
2011
Kapel - Kal
www.kapelkal.com
Company at a Glance
Kapel-Kal Ltd. is a well-established, leading Israeli manufacturer and global exporter of high quality medical and treatment examination equipment. Kapel-Kals over 20 years of expertize and success is highly attributed to its corporate strategy of providing excellent products that are useful, flexible and convenient to install and use. Kapel-Kal offers two categories of products: General (Off-the-Shelf) Products and TailorMade Products. The General Product Category includes a vast variety of beds, treatment tables and chairs. The Tailor-Made Product Category enables Kapel-Kal Ltd. to provide superb products that are designed and built to meet very specialized requirements.

After 20 years of in-depth encounter with the healthcare and treatment industries, through manufacturing, marketing and service, Kapel-Kal had completed its flagship product: the Vision line. This well thought out, revolutionary, modular treatment-table is a base product which was carefully designed to serve its owner for a few decades. The product is practical and cost effective by being able to grow with each customer as that customers needs expand and change over the years. Varied modules are available to broaden the capabilities of the product and expand the type of work that can be performed with it. This one-of-a-kind product effectively serves caregivers of all fields, such as: Physiotherapy, Gynecology, Urology, Dermatology, and Veterinary. It can be used in clinics, laboratories, homes, spas and medical centers for examinations, operations, and treatments. Beyond the products features flexibility, it is also easy to transport, to assemble, and most importantly, to install the add-on modules and accessories, such as adjustable head rests (pneumatic or electrical), addition of side rails, wheels, retractable castors and much more.
Goal
Objectives: To export our products to distributers, medical centers and colaboration. Target Businesses: Cooperations, distributers, medical centers, clinic chains, manufacturer, universities. Target Countries: United States, Western Europe, Japan, Ukraine, Kazakhstan, Tailand, India.
2011
Medigus Ltd.
www.medigus.com
Company at a Glance
Medigus is a medical device company specializes in developing innovative endoscopic procedures and devices. Medigus is a pioneer developer of the SRS - a unique proprietary endoscopic device for the treatment of GERD, one of the most common chronic diseases in the western world. In addition, Medigus developed a line of miniatuearlysere video cameras, including models that are the smallest in the world. Based on its proprietary technologies, Medigus designs and manufactures endoscopy systems, for partner companies, including major players in the medical device industry as well as promising start-ups. Medigus advanced technology platform includes all necessary elements for performing a wide range of endoscopic procedures. The platform includes various types of rigid, semi-flexible and flexible video endoscopes, as well as respective endoscopy suites. From Concept-to-Product, we leverage our existing technological building blocks and combine the exceptional capabilities of our top medical and engineering experts to develop full-fledged medical devices at the highest standards, with exceptional efficiency and at the lowest prices. Medigus was established in 2000 and is a public company traded in the Tel-Aviv stock exchange since 2006.

1. Medigus developed an entire endoscopic system for intraluminal treatment of Reflux Disease (GERD). The innovative system performs an anterior fundoplication in lieu of the current surgical procedure without opening the abdominal cavity. The SRS combines a surgical stapler, ultrasonic sights for accurate positioning and a miniaturized video camera all are Medigus proprietary technologies. The system contains all the requisite tools to complete the entire procedure and is controlled by a single physician. The system has a CE mark and successfully completed an international large-scale multi-center clinical trial. 2. Medigus offers the worlds smallest video cameras. We offer a high performance, low cost, revolutionary CMOS camera, with an outer diameter of only 1.2mm the smallest video camera in the world. The camera offers superb sensitivity, resolution and dynamic sensitivity. In small quantities Medigus provides a multi-use version of the camera, while in large quantities a single-use version is provided. The disposable camera eliminates the need for the costly sterilization. The camera is designed for endoscopes and in diagnostic and surgical medical procedures. We also offer multi-use 3.0x3.0mm and 1.8x1.8mm CCD cameras.
Goal
Objectives: 1. We seek distributors for the SRS endoscopic treatment of GERD. 2. We seek partners interested in developing mini-video-endoscopes based on our proprietary smallest video camera in the world for various medical applications. Target Businesses: 1. Distributors with proven experience in the endoscopic surgery field (i.e., bariatric, minimal-invasive, NOTES) and innovative medical devices. 2. Companies developing mini-endoscopes for medical applications.
2011
Medoc
Category: Diagnostics Neurology and Degenerative Diseases Wound and Pain Management
www.medoc-web.com
Company at a Glance
Medoc is a leading manufacturer of neuro-diagnostic medical systems and advanced thermal stimulators for the assessment of chronic pain. Medoc's products evaluate the small and large peripheral sensory nerve fibers (A-delta and C fibers), constituting the "Pain Pathway". In 2006, Medoc established the "Medoc Israel" division. This division represents companies world-wide, promoting and distributing their advanced medical solutions to the Israeli market. Medoc Ltd. has developed several strategic collaborations with leading international suppliers from the USA and Europe including Boston Scientific for treating severe and chronic pain patients by implanting advanced spinal cord stimulation (SCS) device, Neurotherm for treatment of local pain by applying Radio Frequency (RF) directly to the pain source, Epimed for nerve block solutions and catheters and HydroCision for minimal invasive disc-ectomy.
Company Status Revenue Growth

The PATHWAY Pain and Sensory Evaluation System offers new applications for advanced pain research and fMRI. The PATHWAY model CHEPS (Contact Heat-Evoked Potential Stimulator) marks a breakthrough in the field of pain-evoked potential, allowing objective assessment of evoked pain. The PATHWAY model ATS (Advanced Thermal Stimulator) and PATHWAY model CHEPS are currently used in fMRI studies and in advanced pain research. The TSA-II Thermal Sensory Analyzer is used in QST (Quantitative Sensory Testing) to clinically evaluate small nerve fibers (A-delta and C fibers). The VSA-3000 Vibratory Sensory Analyzer is used in the assessment of large peripheral nerve fibers (A-beta). The recently launched Computerized Algometer is a new software-based system, providing real-time visual and auditory feedback to control and monitor applied pressure rates. Medoc will launch a series of clinical devices in the coming year to 4 years. Medoc is also interested in expanding its scope of products in the Israeli market by signing partnership agreements with promising medical device companies offering breakthrough technology and innovative products.
Goal
Objectives: Looking for representatives / distributors. Medoc is curretnly in the process of penetrating the clinical market, and seeking potential collaborations with international companies which are active in the clinical field. Medoc is also interested in expanding its scope of products (for the Israeli market only) and in signing exclusive distribution agreements with promising medical device companies offering breakthrough technology and innovative products. Target Businesses: Distributors; Medical devices companies offering breakthrough technologies; Distributing channels for the clinical field. Target Countries: Optional
2011
Mizra Medical
Category: Disposables and Implantable Urology General Health Infection Control and Infectious Diseases
www.mizramedical.com
Company at a Glance
Mizra Medical Ltd. developed out of a family business, Mizra Latex Products founded by Mr. Zeev Mizra in 1955. The company was incorporated as Mizra Medical Ltd in 2002 and the company has grown to be the leading producer of latex disposable products in Israel. Mizra carries a complete line of continence care products and distributes specialized products that provide solutions to the challenges faced by the elderly, disabled, and others with special needs.

Mizra Medical carries an extensive line of continence care products and distributes specialized products that provide solutions to the challenges faced by the elderly, disabled, and others with special needs.
Goal
Objectives: Distribution, Alliances Target Businesses: Distributors, Hospitals, Pharmacies Target Countries: Eastern Europe, USA, Canada, South America
2011
Motorika
Category: Medical and Hospital Equipment Robotics Rehabilitation Neurology and Degenerative Diseases General Health
www.motorika.com
Company at a Glance
Motorika is a leader in manufacturing robot-assisted solutions to meet the therapeutic needs of patients suffering from a variety of neurological conditions, including stroke, traumatic brain injury, spinal cord injury, as well as orthopedic and post-surgery dysfunction. Motorika's products include upper and lower extremities function, providing better rehabilitation results through a combination of wide variation and intense repetition.

ReoGo is the worlds most advanced robotic system for upper limb therapy, designed to facilitate three-dimensional repetitive arm movements through the use of an advanced, fully motorized robotic arm. The system is suited for a wide variety of patients in all stages of stroke recovery. ReoAmbulator is a high-end robotic gait training device that integrates Body WeightSupport Treadmill Training (BWSTT) with advanced robotics to help rehabilitate patients who experience problems with ambulation, balance, coordination, posture or stamina.
Goal
Objectives: Generate interest from doctors and physiotherapists Target Businesses: Hospitals, rehabilitation clinics Target Countries: Worldwide
2011
NanoVibronix
Category: Urology Wound and Pain Management Infection Control and Infectious Diseases Medical and Hospital Equipment
www.nanovibronix.com
Company at a Glance
NanoVibronix develops innovative medical devices based on its proprietary therapeutic acoustic technology. The company two main product lines are for catheter related complications and for treatment of wounds, soft tissue and pain in a range of clinical applications.

UroShield - prevents biofilm formation on catheters, thereby decreasing risk for urinary tract infection, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. PainShield - accelerate healing of soft tissue, non-union of fractures and relief of pain. WoundShield - accelarates wound healing.
Goal
Objectives: Expand distribution network Target Businesses: Distributors to hospitals, clinics, home-care Target Countries: Germany, France, Italy, UK, Spain, Scandinavian countries, US and Asia
2011
Nava Group
Category: Disposables and Implantable General Health
www.navagroup.co.il
Company at a Glance
We at NAVA GROUP LTD. are in the protective healthcare business since 1970. Nava Group is among the market leaders in the top grade of quality for absorbent products, specializing in adult incontinence care. Our main products are adult diapers and bed pads. Our manufacturing plant is located in Hatzor Haglilit, Israel, and we maintain large warehouse inventories for immediate shipment via our distribution channels. NAVA GROUP LTD is a private label manufactory. We support our customers on marketing and consulting. We offer wide range of adults' diapers according to customers' specifications. Our products are successfully sold in European and US markets, including TEVA, and are based on experience of thousands of healthcare providers from around the world. We provide the highest quality in a modern and unique technology. Our MISSION is to offer our customers the best value for the money they spend as well as the assurance that they will provide their clients with the best level of comfort and security.

Chlorine-free Hypoallergenic Latex free Fragrance free, neutralized odor technology Highest quality SAP Supervised controlled forestry for our fluff pulp Higher absorbency = using less diapers ISO 9001 quality management
Goal
Objectives: Find new private label clients Target Businesses: Distributors, hospitals, old-age homes, pharmacies Target Countries: Worldwide
2011
Noam Urim Enterprises

Category: Disposables and Implantable Industrial OEM General Health Infection Control and Infectious Diseases
www.noam-urim.com
Company at a Glance
Noam Urim Enterprises Ltd. is one of the largest non-woven needle punch producers in the Middle East. Established in 1976 , it supplies various fabrics/substrates for medical use, including soaped sponge/gloves, antibacterial cleaning cloth, white needle punch for personal care and cloth for cosmetic applications. Noam Urim supplies rolled fabrics that serve as raw material. Customers include wet wipes producers and converters for many other spheres: cosmetics, medical (hospitals, hotels etc.) and cleaning products. We can define the perfect fiber blend for any application in all packaging phases from big mother rolls to bulk packaging and private label. We produce tailor-made articles and runs for fast development. The company is IS0 9001:2000 certified, assuring the highest standard of quality for all products, which are exported worldwide.

Soaped sponge gentle soap especially designed for personal healthcare in hospitals and other health centers. When the sponge makes contact with water, the cleaning agent is activated. The wipe substrate can be impregnated with almost any soap or detergent perfect for practically any purpose. The growing demand for wet wipes and the need for constant upgrading of the product means increased demand for needle punch material for dry application. Dry version of soaped sponge Lightweight 2 in 1, replacing need for soap and sponge separately Single-use Long-lasting Many applications: personal care, pet care, general cleaning, car care and more Ideal for daily use and sensitive skin Antibacterial Wipes provide permanent built-in protection against the growth of bacteria, mold, fungi and yeast. Long-lasting antibacterial protection does not wash off. Unique treatment during production ensures wipes are non-allergenic, safe, can be used longer and are more hygienic. Cosmetic Dots wipes containing dots (from gentle to abrasive). White needle punch - produced in big mother rolls for hygiene, >90 sqm ,min 15cm width (gloves).
Goal
Objectives: Distribution, alliances, customers (converters and private label) Target Businesses: Hospitals, clinics, cosmetics Target Countries: Worldwide
2011
OHK Medical Devices

Category: Medical and Hospital Equipment General Surgery Disposables and Implantable
www.hemaclear.com
Company at a Glance
The creators of HemaClear saw the need for a new, different kind of tourniquet, one that would be simple, safe, sterile, and more cost-effective than any device on the market today. So they had a vision, and realized it. HemaClear is the first and only single-use device that exsanguinates, occludes, and provides a clearer surgical field. Beginning with a sterile field allows surgeons to place the device closer to the site than ever before. Its narrower size provides a larger, dryer, and clearer surgical field, for a better view of anatomical structures. Instant, on-the-spot sterility, and greater access to the surgical site assures a safer, more successful surgical outcome. Its innovative technology not only reduces blood loss, infection, and the volume of ischemic tissue, its simplicity saves precious OR set-up time as much as fifteen minutes and over 100 separate steps that can add as much as $300 to every procedure. In fact, HemaClear is so revolutionary, it represents the single greatest advance in tourniquet technology since the Esmarch bandage. HemaClear has been proven worldwide in over 150,000 surgical cases from the OR to disaster-struck areas all around the world. (The recent earthquake in Haiti).

HemaClear is designed to create a bloodless field for limb surgery, quickly and effectively without wasting precious time and materials. In the center of the device, a specially engineered silicone ring exerts just enough circumferential pressure as it rolls up the limb to exsanguinate completely and occlude the blood vessels - without damaging soft tissue and nerves. Factory calibrated and pre-set, HemaClear delivers uniform and reproducible results. Full range of sizes to accommodate almost every patient type, from pediatric to obese (limb circumference of 14 to 90 cm).
Goal
Objectives: Develop a distribution network Target Businesses: Orthopedic surgeons Target Countries: Germany, Belgium, Holland, Switzerland, Scandinavia
2011
Polytex Technologies
www.polytex.co.il
Company at a Glance
Polytex Technologies Ltd. provides advance solutions for textile management such as distribution of uniforms, garments, special wear for clean rooms, operating rooms scrubs, hotel towels, etc. The Polytex solution is based on unique, patented developments, which provides the Polytex systems great advantages in terms of speed and reliability of service, capacity and costs. Our systems are installed at various sites from factories as Intel R&D center to medical centers like Hadassa Medical Center in Jerusalem and Val d'Hebron in Barcelona.

The Polytex products are divided into textile dispensing units and textile return units for various applications. all our products are based on a patented technology, developed by Polytex. The Polytex technology allows our systems to distribute folded items. When compared to existing solutions in the world, our systems provides the best solution in terms of speed and reliability in distributing the textile items, speed in loading the items to the system, very low maintenance needs, high capacity and relatively low costs.
Goal
Objectives: To find potential clients and distributors Target Businesses: Hospitals, industrial laundries, dealers and distributors of industrial machinery for laundries, dealers and distributors of hospital logistics systems Target Countries: Worldwide
2011
Q Core Medical
www.qcore.com
Company at a Glance
Q Core is the innovation leader in medical infusion delivery systems. A medical device company totally focused on the medical infusion pump market, Q Core has developed the most versatile, accurate and reliable infusion pump system platform available. The platform, based on proprietary, patented technology, delivers multi-therapy and dedicated infusion pump systems and disposables (sets) for hospital and ambulatory care environments. Q Cores infusion pump systems improve drug delivery safety for patients and medical staff and offer outstanding reliability and low-cost maintenance that together ensure a low total cost of ownership. The platform is adaptable to changing regulatory and market requirements, enabling hospitals to be confident of long-term value from their infusion pump investment.
Company Status: Worldwide sales
Technology & products

Q Cores flagship family of Sapphire infusion pump systems provides a comprehensive answer for medication infusion delivery in hospital and ambulatory care environments. The Sapphire family stands out in its ability to satisfy a wide range of increasingly challenging drug delivery needs and its ready adaptability to ever-developing clinical requirements. The Sapphire large-volume pump provides all the performance, functionality and ease of use that hospitals require, from critical care settings in hospitals to meeting patient needs at home. The Sapphires low weight and small size free-up overcrowded bedside real estate and ease patient ambulation. The Sapphire multi-therapy pump is the flagship product in a line that also includes dedicated models for TPN, PCA, epidural and drug-specific delivery.
Goals
Target Businesses: Distributors of infusion pumps Target Countries: Worldwide
2011
Shina Systems
Category: Telemedicine and Healthcare IT Cardiovascular and Peripheral Vascular
www.shina-sys.com
Company at a Glance
Shina Systems develops and markets clinical image management and analysis application software. The company has gained market leadership through its proprietary, automated image segmentation tools and intuitive, clinician-friendly application workflow. Clinically effective and technologically distinguished, Shinas software is installed in thousands of clinical sites worldwide, either under its own branding, or under the branding of its OEM partners. Shina released its first independent advanced (3D/4D) visualization (AV) product to the market in 2003. CardioCT, the markets first automated cardiac CT analysis application, was subsequently licensed to Philips CT division. In 2008, Shina started R&D efforts to develop its next-generation 3Di solution, a new advanced medical image management and visualization solution aimed at imaging centers, teleradiology centers and hospitals around the world. The 3Di platform is now available in cloud-based, client-server and stand-alone workstation deployments allowing clinicians, healthcare providers, and patients to access 2D/3D medical imaging from anywhere, whether for clinical analysis of an imaging study or viewing images intuitively in a personal health record.
Company Status: Regulatory Approval

3Di Cloud - 3Di is an innovative, cloud-based image management and advanced (3D/4D) visualization software suite that turns any Internet-connected PC into a comprehensive image processing workstation. It eliminates costly dedicated storage servers and workstations, while providing industry-leading interactive image viewing and advanced visualization features. 3Di Enterprise - A PACS server and advanced visualization solution with the server installed on-site or in a data-center. 3Di Enterprise receives imaging data from DICOM imaging modalities, applies sophisticated assignment rules and auto-routing to other DICOM systems and then archives them in a central database system. The system enables management and access to imaging data through an unlimited number of clients throughout the enterprise network and across multiple connected sites. 3Di Workstation - An advanced multi-modality viewing and analysis software suite for Windows PCs. Includes Previewer, a fast 2D/3D multi-modality, multi-monitor review application, as well as 3Di Viewer, a high-quality full 3D/4D (MPR, MIP, volume rendering and related techniques) diagnostic viewer, and Cardiac CT analysis tool, CT Colonoscopy, PET-CT Fusion and others.
Goal
Objectives: To be recognized as the market innovator and a benchmark of excellence for imaging solutions for all modalities. Target Businesses: Dealers\ Distributers of Pacs/Advanced visualization solutions. Dealers\ Distributers that sale to Radiologists and image centers. Teleradiology companies. Imaging centers chains. Target Countries: All
2011
Sialo Technology Israel

Category: Diagnostics Disposables and Implantable Medical and Hospital Equipment
www.sialotechnology.com
Company at a Glance
Sialo Technology provides medical solutions for the treatment of salivary gland diseases, dentistry and other oral conditions and allows physicians to perform minimally invasive procedures in their clinics. Sialo Technology has been granted several international patents on a range of medical devices.

Sialo Technology offers a tiny endoscope to enable vastly improved visibility of the area under treatment, thereby markedly increasing the success rate of root canal and dental implant procedures and preventing secondary complications. New innovated dental implant with internal structure which acts as a drug delivery system. The Modular Endoscope offered by Sialo Technology has very small diameters: 0.59mm (6,000 pixel, 70 field of view) and 0.93mm (10,000 pixel, 120 field of view - UNIQUE) that can be used with different size sterile disposable cannulas, solving the decontamination problem of miniature endoscopes. Innovative endoscopic technique for root canal and dental implantology moving dentistry a major step forward. One endoscope for several procedures. Sterile disposable cannulas used with endoscope saves on unnecessary sterilization procedure.
Goal
Objectives: Worldwide marketing by cooperation with distributors. Target Businesses: Worldwide distributors Target Countries: Worldwide
2011
Sion Biotext Medical

Category: Disposables and Implantable Cardiovascular and Peripheral Vascular Wound and Pain Management Infection Control and Infectious Diseases
www.sb-medical.com
Company at a Glance
Sion Biotext Medical Ltd. Is a leading manufacturer of single-use skin cleansing and treatment, wound care and surgical solutions for the professional health care sector. The rich product formulations provide additional values, in the cost per unit as well as the volumes needed for each usage. Sion Biotext medical provide the products in a variety of package sizes and dispensing options, each one designed to address specific uses and needs. Our products are nurse orientated although technology is driving physician interest. We seek to reduce the cost of healing to the healthcare provider. The companys quality system is accredited to ISO 9001, ISO 13485 and GMP regulations. The products bear the CE mark certification and F.D.A.

Cleansing and Care Line offers a wide range of skin antisepsic products used to minimize infections caused by skin pathogens, and include: Chlorhexidine (0.5%) and Alcohol Prep Pads P.V.P Prep Pads and Swabsticks Alcohol Prep Pads and Swabsticks Lemon Glycerin Swabsticks Electrode Skin Prep Pads Adhesive Tape Remover Pads SkinCoat Prep Pads Skin Care and Patient Treatment products are delivered in pharmaceutical grade bases and serve to protect the skin and maintain optimal skin integrity, and include: Sterile Lubrican Jelly First Aid Ointments and Creams Zinc Oxide, Vitamin AandD Ointment Petrolatum Ointment Wound Care Line combining the traditional bandage and the impregnating technology resulted in a new age product line: Zinc/Calamine Paste/bandages for the management of venous leg ulcers and Ice Cool Elastic Bandages, a revolutionary product designed to deliver cold and compression to the afected area for treatment of sport injuries bruises, inflamations and sprains. Surgical Line offers complete solution in the operating theatre by providing products such as drapes, packs and staff clothing, customised procedure packs/trays.
Goal
Objectives: Distribution, alliances Target Businesses: Clinics, hospitals, home care Target Countries: Europe, US, Canada, South America, Australia
2011
TavTech
Category: Medical and Hospital Equipment Aesthetics and Dermatology
www.tav-tech.com
Company at a Glance
TavTech Ltd. is an innovator of state-of-the-art technology, incorporating jet aviation principles and engineering. TavTech's unique systems use only natural components air (or medical gas) and water - accelerated to supersonic speeds to achieve the desire effect on tissue. The technology is patented and has broad application across the medical spectrum. Aesthetic Medicine and Cosmetology TavTech's industry-leading exclusive technology brings new dimensions to Aesthetic Medicine. TavTech's JetPeel systems provide multi-functional skin rejuvenation using nature's own elements - air, oxygen (or other medical gas) and saline solution. They are designed for skin rejuvenation, facial resurfacing, removal of age and hyperpigmentation spots, peri-oral wrinkles, facial deep cleansing (pores, comedones) and moisturizing, and for use on scars, acne, stretch marks, scalp and a variety of other applications, all painlessly. Jet-M that is perfectly positioned to meet the needs of the changing market. Jet-M provides non-traditional physicians, medspas, and para-medical practitioners, affordable, multi-function treatment procedures for the aesthetic market. Please visit our website www.tav-tech.com.

Jet aviation engineering is being used by TavTech to meet the needs of the rapidly expanding aesthetic, skin care and wound management markets. TavTech's patented technology creates two-phase jet of micro-droplets consisting of saline solution and gas (air or medical gas) that is accelerated to velocities that reach 200m/sec., providing a versatile and precise means for performing a wide variety of skin treatments. The pressure created by the high-velocity jet stretches the skin at the point of contact, causing "barophoresis" due to pressure variance; the skin in the high- pressure zone forms a concave surface and micro-canals in the outer layer of the skin broaden as the skin stretches and new canals are created. This process facilitates hydration, cleansing and purifying of the treated area, opens access to the skin's inner layers, allowing for deeper penetration, and the introduction of vitamins, anti-aging and other solutions.
Goal
Objectives: Identify partners/distributors Target Businesses: Qualified partners/distributors Target Countries: Germany, Australia, France
2011
Toefix ltd.
Category: Disposables and implantable
www.toefix.co.il
Company at a Glance
ToeFIX is an Israeli registered company that develops OTC medical devices which replace common foot surgical procedures. The company has developed a unique and proprietary treatment for the ingrown toenail problem. The company intends to extend its line of business with several products in the arena of foot problems treatment, which all replace surgical interventions. Toefix operates out of two sites:R&D centre in Haifa, manufacturing and distribution centre in Taoz, nearby Jerusalem. The company develops, produces and markets innovative medical devices.

1) Toefix ingrown toenail device got FDA and CE approval (by ISO 13485) and successfully passed Helsinky human trials with success rate of 93.3% (28 out of 30 patients were successfully treated with no complications or side effects, while the follow-up for the first cases is now more than a year), since then many more patients got the treatment provided by doctors and pedicurists with similar success rate. The device is now in marketing stage in Israel and going to be marketed to Europe and the USA in coming months. 2) A sock for clawtoe(s) and hammertoe(s) gradual repetitive correction, produced in a variety of techniques and embodiments, having either separate compartments for each toe or cuts through which a set of restrains might be safely and comfortably anchored to a pad, positioned over the heel bump (aka Tuber Calcanei) mimicking the direction of intrinsic muscles pull, and utilizing weight load bearing as a source of corrective force. Patent has been submitted by the beginning of December 2010. 3) And several more products are available.
Goal
Objectives: Market adaptation, further R&D, sales expansion and strategic partnership Target Businesses: Pharma chains, Medical Practices, Medical Device distributors Target Countries: EU: UK, France, Germany, Netherlands, Italy, Spain, Switzerland; Eastern Europe; USA; B.R.I.C.S.
2011
Ultra Rhino-Therm
www.rhinotherm.com
Company at a Glance
Established in 2005, privately owned Israeli company Ultra Rhino-Therm LTD developed a medical device to treat patients suffering from nasal congestions. The company is operating under ISO 13485. RhinothermUltras Trade Mark is protected in many countries worldwide and the device is patented in the USA and pending in other major countries.

Ultra Rhino-Therm LTD offers medical devices for the treat of patients suffering from nasal congestions associated with the common cold, allergic rhinitis and sinusitis. Ultra technology is based on the hyperthermia concept, the devices work by delivering 100% water-saturated pressurized air at a temperature of 43C (110F) directly to the nasal passages. This quick, effective and drug free treatment offers relief that can last up to several days Rhinotherm Ultra devices are FDA and UL/CE approved devices, and have been subjected to clinical studies in 10 countries and found to be a safe and effective drug-free source of relief for symptoms caused by nasal congestion The original Rhinotherm device was conceived back in 1985, But it was tageted for the use of medical clinics only, today Rhino-Therm LTD offers a new line of products available for home use supporting both 110V (UL), 230V (CE).
Goal
Objectives: Locate growth rising and marketing opportunities
2011
Vasa Applied Technologies

Category: Disposable and Implantable Monitoring Diagnostic Urology
www.vasa-at.com
Company at a Glance
Vasa Applied Technologies Ltd. is a privately-owned Israeli start-up company that developed a patent-pending technology that allows direct flow measurement of secreted body fluids and low cost devices for growing market niches breastfeeding and Urology catheters.

A technology for measuring pulsating low flow rates of fluids excreted and secreted from the body, based on a patent-pending probe. The probe is easily shaped and integrated in measuring units, currently implemented in measuring human milk flow and urine flow, for both hospitals and home environment: 1) The first ever breastfeeding meter - a convenient and simple to operate device that accurately measures the amount of milk a baby ingests during breastfeeding, for supporting breastfeeding. 2) Urine flowmeter - an in-line catheter flowmeter that accurately measures the urine output (flow rate and amount) of a catheterized patient.
Goal
Objectives: Production cooperation; distribution agreements for the two products. Target Businesses: Distributors, medical device manufacturers for strategic partnership Target Countries: Worldwide
2011
Virtual Ports Ltd.

Category: Medical and Hospital Equipment General Surgery
www.virtual-ports.com
Company at a Glance
Founded in May 2006, Virtual Ports Ltd. is a medical device company focusing on developing and marketing patented products that improve minimally invasive procedures.

Minimally invasive surgery (MIS) offers patients significant advantages: less pain, fewer complications, shorter recovery time and smaller scars. However, this notable advance in medical procedure is often compromised by the disadvantages of manual organ retraction an additional port for the grasper and an additional instrument cluttering the operation site. EndoGrab - is a groundbreaking internal retractor which is introduced into the abdominal cavity using a proprietary Applier to expose the operating site by internally anchoring the organ to the abdomen. After anchoring the organ the Applier is removed, allowing the port to be re-used for other purposes. During surgery EndoGrab keeps the organ safely retracted until it can be repositioning or removed once the procedure is completed. EndoLift is a groundbreaking internal retractor that lifts the liver and anchors it to the abdominal wall to expose the underlying organs. EndoLift is hands-free, allowing surgeons to focus on the task at hand. Furthermore, it does not require anchoring to any external device that limits the patients position and adds clutter to the operating table.
Goal
Objectives: To find potential Distributors Target Businesses: Distributors in the Laparoscopy field Target Countries: Europe
2011
Xenolith Medical
Category: Disposables and implantable Medical and Hospital Equipment Urology
www.xenolithmedical.com
Company at a Glance
Xenolith Medical Ltd is developing medical retention devices for endourologists who wish to prevent stone migration to the kidney during ureteroscopy procedures. The use of Xenolith Medicals devices will minimize procedure invasiveness, lower its risk to the patient and shorten procedure time. Using innovative concepts, our products will replace current safety guide wires, stone-retrieval baskets and other stone fragment retrieval devices, thus simplifying the ureteroscopic procedure and reducing overall procedure costs. The first device that is being developed by Xenolith Medical, will change the therapeutic approach for ureteroscopy, allowing endourologists to perform procedures much easier and faster than the ones performed today.
Company Status: Clinical trials Regulatory Approval

The unique approach developed by Xenolith Medical incorporates a very thin and flexible mesh structure as an integral part of a guidewire. The mesh is collapsed into an overlay tube that forms part of this guide wire and allows it to maintain a very slim (less than 1mm) profile. Xenolith Medicals device also has a flexible floppy tip that can be advanced past urethral stones. Much like a guidewire, Xenolith Medicals device can be used either side-by-side to the ureteroscope or introduced through its working channel. Upon ureter introduction the device is advanced beyond the occluding stone until reaches the kidney so the mesh is positioned proximal to the stone (i.e. between the stone and the kidney). Once properly positioned, the overlay tube that retracts the mesh is withdrawn, allowing the mesh to deploy and self-expand. The mesh can self-expand up to 12mm in diameter, fitting to all ureter sizes and shapes applying a carefully pre-calibrated radial force to the ureter wall. The fully deployed mesh acts as a barrier to particles larger than 1mm preventing their migration to the kidney and allowing enhanced irrigation for both better visualization and faster lithotripsy due to stone migration prevention.
Goal
Objectives: Meetings with distributors and strategic partners Target Businesses: Strategic partners Target Countries: Europe
2011
Schedule a Meeting
Contact our commercial attaches around the world at: South Europe and Africa
Paris, France (+33.1)4076-5560 paris@israeltrade.gov.il
North Europe
Central and East Europe

Vienna, Austria (+43.1) 4764-6516 vienna@israeltrade.gov.il
Brussels, Belgium (+32.2) 3735-533/4/5 brussels@israeltrade.gov.il
Milan, Italy (+390.2) 7601-5545 milano@israeltrade.gov.il
London, UK (+44.207) 9579-525 london@israeltrade.gov.il
Warsaw, Poland (48.22+) 5970-514 warsaw@israeltrade.gov.il
Madrid, Spain (+34.91) 782-9520/9 madrid@israeltrade.gov.il
Berlin, Germany (+49.30) 2064-490 berlin@israeltrade.gov.il
Bucharest, Romania (+40.21) 3189-407/8 bucharest@israeltrade.gov.il
Johannesburg, South Africa (+27.11) 7839-605 johannesburg@israeltrade.gov.il
Hague, Netherlands (+31.70) 3760-514 hague@israeltrade.gov.il
Moscow, Russia (+7.495) 7972-737/9 moscow@israeltrade.gov.il
Istanbul, Turkey (+90.212) 3176-547 istanbul@israeltrade.gov.il
Stockholm, Sweden (+46.8) 5280-6580 stockholm@israeltrade.gov.il
Geneva, Switzerland (+41.22) 7160-507 geneva@israeltrade.gov.il
Kiev, Ukraine (+380) 44-5861-552/3 kiev@israeltrade.gov.il
2011
Schedule a Meeting
Contact our commercial attaches around the world at:
North and South America

Sao Paolo, Brazil (+55.11) 3032-3511 saopaolo@israeltrade.gov.il
Asia and Pacific

Sydney, Australia (+61.2) 93880-382 sydney@israeltrade.gov.il
India and China

Beijing, China (+86.10) 8532-0664 beijing@israeltrade.gov.il
Toronto, Canada (+1.416) 6408-540/1 Toronto@israeltrade.gov.il
Tokyo, Japan (+81.3) 3264-0398 tokyo@israeltrade.gov.il
Guangzhou, China (+86. 20) 8513-0518/9 guangzhou@israeltrade.gov.il
Mexico City, Mexico (+52.55) 5201-1511 mexico@israeltrade.gov.il
Seoul, South Korea (+82.2) 723-6121/2 korea@israeltrade.gov.il
Delhi, India (+91.11) 3041-4518 delhi@israeltrade.gov.il
Washington, USA (+1-202) 364-5695 washington@israeltrade.gov.il
Singapore (+65) 68-349-220 singapore@israeltrade.gov.il
Mumbai, India (+91.22) 2202-4643 mumbai@israeltrade.gov.il
Chicago, USA (+1.312) 3322-160 chicago@israeltrade.gov.il
Taipei, Taiwan (+886.2) 2757-7221/2 Taipei@israeltrade.gov.il
Houston, USA (+1.713) 5990-290 houston@israeltrade.gov.il
Bangkok, Thailand (+66.2)2049-240/1 bangkok@israeltrade.gov.il
Los Angeles, USA (+1.323) 6587-924 losangeles@israeltrade.gov.il
Hanoi, Vietnam (+84.43) 843-3140 vietnam@israeltrade.gov.il
New York, USA (+1.212) 4995-610 newyork@israeltrade.gov.il

Medica Catalogue

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Medica Catalogue

Uploaded by

Copyright:

Available Formats

Israel Medical Innovation

Come meet us at hall 16: G40 in

Israel Medical Innovation

Israel Medical Innovation

Table of Contents (by category)

Click on Companys name for more details

Aesthetics and Dermatology

Cnoga Coolsense Erika Carmel Gilco Pharm Tav Tech Ltd

Cardiovascular and Peripheral Vascular

Disposables and Implantable

Return to Table of Content

Israel Medical Innovation

Table of Contents (by category)

Click on Companys name for more details

ETView FirstCare Flight Medical Gilco Pharm

ETView FlowSense Intromedix OHK Medical Devices Virtual Ports

Industrual OEM Infection Control and Infectious Diseases

ETView Flight Medical

Return to Table of Content

Israel Medical Innovation

Table of Contents (by category)

Click on Companys name for more details

Laboratory Equipment Medical and Hospital Equipment

Return to Table of Content

Israel Medical Innovation

Table of Contents (by category)

Click on Companys name for more details

Neurology and Degenerative Disease

Coolsense Medoc Motorica Itamar Medical

Pharmaceuticals Respiratory and Pulmonary

Erika Carmel Itamar Medical Motorica

DYN Diagnostics Flight Medical Motorica

Services Telemedicine and Healthcare IT

Mizra Medical NanoVibronix Vasa Applied Technologies Xenolith Medical

Wound and Pain Management

Erika Carmel Gilco Pharm Medoc NanoVibronix Sion Biotext Medical

Return to Table of Content

Israel Medical Innovation

Table of Contents (by alphabetical order)

Telemedicine and Helathcare IT Services

Industrial OEM Infection Control and Infectious Diseases

Medical and Hospital Equipment Infection Control and Infectious Diseases

E.M.S General Surgery Biovo Technologies

Medical and Hospital Equipment Disposables and Implantable

BSP Biological Signal Processing

Diagnostics Cardiovascular and Peripheral Vascular

Return to Table of Content

Israel Medical Innovation

Table of Contents (by alphabetical order)

Discover Medical Devices

Robotics Laboratory Equipment Medical and Hospital Equipment

Monitoring General Health Diagnostics Monitoring

Erika Carmel Ltd.

Wound and Pain Management Medical and Hospital Equipment Rehabilitation

Return to Table of Content

Israel Medical Innovation

Table of Contents (by alphabetical order)

Medical and hospital Equipment

Disposables and Implantable Intensive Care

First Care Products

Intensive Care Respiratory and Pulmonary E.M.S

Monitoring Medical and Hospital Equipment Pharmaceuticals

Aesthetics and Dermatology E.M.S Wound and Pain Management

Return to Table of Content